These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31902521)

  • 1. Normal brain aging and Alzheimer's disease are associated with lower cerebral pH: an in vivo histidine
    Lyros E; Ragoschke-Schumm A; Kostopoulos P; Sehr A; Backens M; Kalampokini S; Decker Y; Lesmeister M; Liu Y; Reith W; Fassbender K
    Neurobiol Aging; 2020 Mar; 87():60-69. PubMed ID: 31902521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
    Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
    Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.
    Pfefferbaum A; Adalsteinsson E; Spielman D; Sullivan EV; Lim KO
    Arch Gen Psychiatry; 1999 Feb; 56(2):185-92. PubMed ID: 10025444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
    J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Pina MA
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H MR spectroscopy in common dementias.
    Kantarci K; Petersen RC; Boeve BF; Knopman DS; Tang-Wai DF; O'Brien PC; Weigand SD; Edland SD; Smith GE; Ivnik RJ; Ferman TJ; Tangalos EG; Jack CR
    Neurology; 2004 Oct; 63(8):1393-8. PubMed ID: 15505154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of hippocampal pH and neurochemicals from in vivo multi-voxel 31P study in healthy normal young male/female, mild cognitive impairment, and Alzheimer's disease.
    Mandal PK; Akolkar H; Tripathi M
    J Alzheimers Dis; 2012; 31 Suppl 3():S75-86. PubMed ID: 22426021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T; Shiino A; Akiguchi I
    Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease.
    Hattori N; Abe K; Sakoda S; Sawada T
    Neuroreport; 2002 Jan; 13(1):183-6. PubMed ID: 11924885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Various MRS application tools for Alzheimer disease and mild cognitive impairment.
    Gao F; Barker PB
    AJNR Am J Neuroradiol; 2014 Jun; 35(6 Suppl):S4-11. PubMed ID: 24742809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.
    Mihara M; Hattori N; Abe K; Sakoda S; Sawada T
    Neuroreport; 2006 Mar; 17(4):413-6. PubMed ID: 16514368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
    Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.